title: Vasohibin-1 and retinal pigment epithelium.
authors.affiliation: Division of Clinical Cell Therapy, United Center for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 1-1 Seiryoumachi Aobaku Sendai, Miyagi, Japan.
authors.forename: Yumi
authors.initials: Y
authors.lastname: Ishikawa
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Nagai
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Onami
authors.forename: Norihiro
authors.initials: N
authors.lastname: Kumasaka
authors.forename: Ryosuke
authors.initials: R
authors.lastname: Wakusawa
authors.forename: Hikaru
authors.initials: H
authors.lastname: Sonoda
authors.forename: Yasufumi
authors.initials: Y
authors.lastname: Sato
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Abe
mesh_terms: D000818:Animals; D016587:Antimutagenic Agents / Q000494:pharmacology; D018797:Cell Cycle Proteins / Q000235:genetics* / Q000378:metabolism / Q000494:pharmacology*; D002460:Cell Line; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D003035:Cobalt / Q000494:pharmacology; D018076:DNA, Complementary / Q000494:pharmacology; D015870:Gene Expression / Q000502:physiology; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D051381:Rats; D055213:Retinal Pigment Epithelium / Q000166:cytology / Q000187:drug effects* / Q000502:physiology*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D016587:Antimutagenic Agents; D018797:Cell Cycle Proteins; D018076:DNA, Complementary; C493181:VASH1 protein, human; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D003035:Cobalt; C018021:cobaltous chloride